Prospective validation study of the International Classification of Functioning, Disability and Health score in Crohn's disease and ulcerative colitis

Journal of Crohn's and Colitis

Volumn 8, Issue 10, 2014, Pages 1237-1245

  Leong, Rupert W L ^a,c   Huang, Tony ^a,c   Ko, Yanna ^a,c   Jeon, Ari ^a   Chang, Jeff ^a,c   Kohler, Friedbert ^b,c   Kariyawasam, Viraj ^a  

^a Department of Microbiology and Infectious Diseases   (Australia)

^b Braeside Hospital   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Colitis; Crohn's; Disability; Employment; Inflammatory bowel disease; Work

Indexed keywords

BIOLOGICAL PRODUCT;

ABSENTEEISM; ADOLESCENT; ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATIONAL STUDY; CROHN DISEASE; CROHN DISEASE ACTIVITY INDEX; FEMALE; HUMAN; INTERNATIONAL CLASSIFICATION OF FUNCTIONING, DISABILITY AND HEALTH; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PARTIAL MAYO SCORE; PROSPECTIVE STUDY; QUALITY OF LIFE; SCORING SYSTEM; ULCERATIVE COLITIS; UNEMPLOYMENT; VALIDATION STUDY; CASE CONTROL STUDY; CLINICAL TRIAL; COMPLICATION; DISABILITY; EMPLOYMENT; PRODUCTIVITY; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; SEVERITY OF ILLNESS INDEX;

ABSENTEEISM; ADULT; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; DISABILITY EVALUATION; EFFICIENCY; EMPLOYMENT; FEMALE; HUMANS; INTERNATIONAL CLASSIFICATION OF FUNCTIONING, DISABILITY AND HEALTH; MALE; PROSPECTIVE STUDIES; QUESTIONNAIRES; ROC CURVE; SEVERITY OF ILLNESS INDEX;

EID: 84908246510     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2014.02.028     Document Type: Article

References (29)

1. World Health Organization Document A29/INFDOCI/1 1976, [Geneva, Switzerland].
2. Peyrin-Biroulet L. What is the patient's perspective: how important are patient-reported outcomes, quality of life and disability?. Dig Dis 2010, 28(3):463-471.
3. Kohler F., Selb M., Escorpizo R., Kostanjsek N., Stucki G., Riberto M. International Society of Physical and Rehabilitation Medicine Sub-Committee Implementation of the ICF; Participants of the São Paulo ISPRM - World Health Organization Workshop. Towards the joint use of ICD and ICF: a call for contribution. J Rehabil Med 2012, 44(10):805-810.
4. World Health Organization International Classification of Functioning, Disability and Health: ICF 2001, WHO, Geneva, Switzerland, [http://www.who.int/classifications/icf.appareas/en/index.html (accessed 28 May 2013)].
5. Okochi J., Takahashi T., Takamuku K., Escorpizo R. Staging of mobility, transfer and walking functions of elderly persons based on the codes of the International Classification of Functioning, Disability and Health. BMC Geriatr 2013, 13:16.
6. Grill E., Stucki G. Scales could be developed based on simple clinical ratings of International Classification of Functioning, Disability and Health Core Set categories. J Clin Epidemiol 2009, 62(9):891-898.
7. Kohler F., Xu J., Siva-Withmory C., Arockiam J. Feasibility of using a checklist based on the ICF as an outcome measure in individuals following lower limb amputation. Prosthet Orthot Int 2011, 35:294-301.
8. Saketkoo L.A., Escorpizo R., Keen K.J., Fligelstone K., Distler O. ESUSTAR. International Classification of Functioning, Disability and Health Core Set construction in systemic sclerosis and other rheumatic diseases: a EUSTAR initiative. Rheumatology Dec 2012, 51(12):2170-2176.
9. Oberhauser C., Escorpizo R., Boonen A., Sticki G., Cieza A. Statistical validation of the brief International Classification of Functioning, Disability and Health Core Set for osteoarthritis based on a large international sample of patients with osteoarthritis. Arthritis Care Res 2013, 65(2):177-186.
10. Peyrin-Biroulet L., Cieza A., Sandborn W.J., Coenen M., Chowers Y., Hibi T., et al. International Programme to Develop New Indexes for Crohn's Disease (IPNIC) group. Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health. Gut Feb 2012, 61(2):241-247.
11. Achleitner U., Coenen M., Colombel J.F., Peyrin-Biroulet L., Sahakyan N., Cieza A. Identification of areas of functioning and disability addressed in inflammatory bowel disease-specific patient reported outcome measures. J Crohns Colitis Jun 2012, 6(5):507-517.
12. Silverberg M.S., Satsangi J., Ahmad T., Arnott A.D., Bernstein C.N., Brant S.R., et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005, 19(Suppl. A):5-36.
13. Guyatt G., Mitchell A., Irvine E.J., Singer J., Williams N. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 1989, 96:804-810.
14. Best W.R., Becktel J.M., Singleton J.W., Kern F. Development of a Crohn's disease activity index: National Cooperative Crohn's Disease Study. Gastroenterology 1976, 70:439-444.
15. Schroeder K.W., Tremaine W.J., Ilstrup D.M. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis: a randomized study. N Engl J Med 1987, 317:1625-1629.
16. Sonnenberg A. Disability and need for rehabilitation among patients with inflammatory bowel disease. Digestion 1992, 51(3):168-178.
17. Leong R.W., Lee Y.T., Ching J.Y., Sung J.J. Quality of life in Chinese patients with inflammatory bowel disease: validation of the Chinese translation of the Inflammatory Bowel Disease Questionnaire. Aliment Pharmacol Ther 2003, 17:711-718.
18. Ward F.M., Bodger K., Daly M.J., Heatley R.V. Clinical economics review: medical management of inflammatory bowel disease. Aliment Pharmacol Ther 1999, 13:15-25.
19. Feagan B.G., Vreeland M.G., Larson L.R., Bala M.V. Annual cost of care for Crohn's disease: a payor perspective. Am J Gastroenterol 2000, 95:1955-1960.
20. Picone D. Disability - people with a disability: responding to needs during hospitalization revised Jan 08, [accessed Jun 2013]. http://www0.health.nsw.gov.au/policies/pd/2008/pdf/PD2008_010.pdf.
21. Feagan B.G., Bala M., Yan S., Olson A., Hanauer S. Unemployment and disability in patients with moderately to severely active Crohn's disease. J Clin Gastroenterol May-Jun 2005, 39(5):390-395.
22. Boonen A., Dagnelie P.C., Feleus A., Hesselink M.A., Muris J.W., Stockbrügger R.W., et al. The impact of inflammatory bowel disease on labor force participation: results of a population sampled case-control study. Inflamm Bowel Dis Nov 2002, 8(6):382-389.
23. Blomqvist P., Ekbom A. Inflammatory bowel diseases: health care and costs in Sweden in 1994. Scand J Gastroenterol 1997, 32:1134-1139.
24. Casellas F., Vivancos J.L., Sampedro M., Malagelada J.R. Relevance of the phenotypic characteristics of Crohn's disease in patient perception of health-related quality of life. Am J Gastroenterol 2005, 100:2737-2742.
25. Lunney P.C., Leong R.W.L. Review article: ulcerative colitis, smoking and nicotine therapy. Aliment Pharmacol Ther 2012, 36(11-12):997-1008.
26. Longobardi T., Jacobs P., Bernstein C.N. Work losses related to inflammatory bowel disease in the United States: results from the National Health Interview Survey. Am J Gastroenterol 2003, 98:1064-1072.
27. Bernklev T., Jahnsen J., Henriksen M., Lygren I., Aadland E., Sauar J., et al. Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis 2006, 12(5):402-412.
28. Allen P.B., Kamm M.A., Peyrin-Biroulet L., Studd C., McDowell C., Allen B.C., et al. Development and validation of a patient-reported disability measurement tool for patients with inflammatory bowel disease. Aliment Pharmacol Ther Feb 2013, 37(4):438-444.
29. Hamilton B.B., Granger C.V, Sherwin F.S., Zielezny M., Tashman J.S. A uniform national data system for medical rehabilitation. Rehabilitation outcomes: analysis and measurement 1987, 137-147. Brookes, Baltimore, MD. M.J. Fuhrer (Ed.).